Increased frequency of a null-allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies

Pharmacogenetics

Volumn 7, Issue 3, 1997, Pages 235-239

  Schulz, Wolfgang A ^a   Krummeck, Angelika ^a   Rösinger, Ingrid ^a   Eickelmann, Peter ^a   Neuhaus, Christine ^b   Ebert, Thomas ^a   Schmitz Dräger, Bernd J ^a   Sies, Helmut ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Redox cycling; Renal cell carcinoma; RFLP PCR; Urothelial carcinoma

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UROGENITAL TRACT CANCER;

ALLELES; CARCINOMA; CARCINOMA, RENAL CELL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; NAD(P)H DEHYDROGENASE (QUINONE); ODDS RATIO; UROLOGIC NEOPLASMS;

EID: 0030857876     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199706000-00008     Document Type: Article

References (14)

1. Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem Pharmacol 1995: 49, 127-140.
2. Eickelmann P, Schulz WA, Rohde D, Schmitz-Dräger B, Sies H. Loss of heterozygosity at the NAD(P)H:quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. Biol Chem Hoppe-Seyler 1994a: 375, 439-445.
3. Eickelmann P, Ebert T, Warskulat U, Schulz WA, Sies H. Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases α and π in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogenesis 1994b: 15, 219-225.
4. Ernster L. DT diaphorase: a historical review. Chemica Scripta 1987: 27A, 1-13.
5. Jaiswal AK, McBride OW, Adesnik M, Nebert DW. Human dioxin-inducible NAD(P)H:menadione oxidoreductase. J Biol Chem 1988: 263, 13572-13578.
6. Joseph P, Xie T, Xu Y, Jaiswal AK. NAD(P)H:quinone oxidoreductasel (DT-diaphorase): expression, regulation, and role in cancer. Oncol Res 1994: 6, 525-532.
7. Kappus H, Sies H. Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia 1981: 37, 1233-1241.
8. Kolesar JM, Kuhn JG, Burris HA III. Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer. J Natl Cancer Inst 1995: 87, 1022-1024.
9. Kuehl BL, Paterson JWE, Peacock JW, Paterson MC, Rauth AM. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer 1995: 72, 555-561.
10. Marshall RS, Paterson MC, Rauth AM. DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer-prone family. Carcinogenesis 1991: 12, 1175-1180.
11. Riley JA, Workman P. DT-diaphorase and cancer chemotherapy. Biochem Pharmacol 1992: 43, 1657-1669.
12. Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics 1995: 5, 199-206.
13. Smith CAD, Smith G, Wolf CR. Genetic polymorphisms in xenobiotic metabolism. Eur J Cancer 1994: 30A, 1935-1941.
14. Traver RD, Horikoshi T, Daneberg DK, Stadlbauer THW, Danenberg PV, Ross D, Gibson NW. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 1992: 52, 797-802.